SELLAS Life Sciences Group, Inc. SLS Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s total costs & expenses?
- SELLAS Life Sciences Group, Inc. (SLS) reported total costs & expenses of $9.25M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s total costs & expenses changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s total costs & expenses increased by 52.6% year-over-year, from $6.06M to $9.25M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s total costs & expenses?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s total costs & expenses has grown at a -3.7% compound annual growth rate (CAGR), from $32.89M to $28.27M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating expenditures incurred by the company during a specific reporting period, including research and development activities and general administrative overhead. It serves as a primary indicator of the company's operational burn rate and the financial resources required to sustain clinical development programs. Monitoring this figure is essential for assessing the efficiency of capital deployment in the pursuit of regulatory milestones and therapeutic commercialization.